BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sforza D, Iaria G, Petagna L, Parente A, Anselmo A, Sergi F, Marzio S, Corrado F, Telli S, Manzia TM, Tisone G. Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome. Transplant Proc 2019;51:140-2. [PMID: 30655129 DOI: 10.1016/j.transproceed.2018.04.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Danguilan RA, Lamban A, Pamugas GEP. Pilot Study Comparing the Efficacy, Safety, Convertibility, and Tacrolimus Trough Levels of Twice-Daily Tacrolimus (Prograf) to Once-Daily Tacrolimus (Advagraf) Among Standard-Risk Kidney Transplant Patients at the National Kidney and Transplant Institute. Transplant Proc 2019;51:2615-9. [PMID: 31563241 DOI: 10.1016/j.transproceed.2019.05.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Parodi E, La Porta E, Russo R, Marsano L, Bellino D, Paoletti E, Massarino F, Sofia A, Garibotto G, Esposito P, Murugavel A, Cappadona F, Fontana I, Viazzi F, Picciotto D. Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study. Transplantation Proceedings 2020;52:3112-7. [DOI: 10.1016/j.transproceed.2020.02.149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 van Zanten R, de Weerd A, Betjes M, Boer-Verschragen M, Massey EK. Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transpl Int 2021;34:1703-11. [PMID: 34448273 DOI: 10.1111/tri.13993] [Reference Citation Analysis]